Medicine for treating Alzheimer disease

Abstract

The invention discloses medicine for treating the Alzheimer disease. The medicine comprises, by weight, 20 parts of prepared rehmannia roots, 15 parts of acorus calamus, 10 parts of polygonum multiflorum, 25 parts of salvia miltiorrhiza, 10 parts of ligusticum wallichii, 12 parts of corylus avellana, 18 parts of citrullus colocynthis, 8 parts of balanophora polyandra, 15 parts of polygala tenuifolia, 8 parts of radix bupleuri, 8 parts of oysters, 18 parts of tea oil, 12 parts of borassus flabellifer, 8 parts of astragalus membranaceus, 12 parts of wolfberry fruit, 5 parts of cordia dichotoma, 5 parts of round-root aristolochia debilis, 6 parts of medical stone, 6 parts of aizoon stonecrop herbs and 4 parts of Chinese ilex leaves. Clinical trials prove that the medicine has the remarkable effect of treating the Alzheimer disease by selecting the proper medicinal materials and the proper ratio of the medicinal materials, and is safe and free of toxic and side effects.

Description

Technical field [0001] The invention relates to a traditional Chinese medicine decoction, in particular to a medicine for treating senile dementia. Background technique [0002] Alzheimer's disease, also known as senile psychosis, is a progressive degenerative disease of the brain. This disease is dominated by brain atrophy and degeneration, and its intelligence is damaged to varying degrees. The clinical manifestation is dementia. The age of onset of this disease is mostly after 60 years old, more common in 70-80 years old, women have a higher incidence rate than men, about 1.5:2.1. According to reports, the incidence of senile dementia over 65 years old in developed countries is 10%, while it can be as high as 20% over 80 years old. With the improvement of our country's living standards and the extension of people's average life expectancy, the incidence of this disease is increasing, and it has become one of the important topics in geriatrics. At present, the treatment of...

AI Technical Summary

Problems solved by technology

Drugs commonly used in clinical treatment of this disease, such as cholinesterase inhibitors - donepezil, calcium ion antagonists - nimodipine and aniracetam, etc., but because the above drugs have nausea, vomiting, bradycardia and severe Adverse reactions such as liver and kidney toxicity greatly limit its application

For the prevention and treatment of senile dementia, there is still a lack of generally recognized safe and effective drugs